Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      India Ranbaxy Q3 profit jumps, beats forecast


      Ranbaxy, controlled by Japan's Daiichi Sankyo (4568.T), said consolidated net profit stood at 3.08 billion rupees ($69.5 million) for the fiscal third-quarter ended September. This compared with 1.15 billion rupees reported a year earlier.

      A Reuters poll had forecast net profit of 1.4 billion rupees for the firm, which is reporting its first quarter of results under a new chief executive who took over in August. Last month, rival Dr Reddy's Laboratories Ltd (REDY.BO) topped estimates with a 32-percent jump in quarterly profit boosted by strong sales in the domestic market. [ID:nSGE69O02L].

      Ranbaxy shares, which the market values at $5.7 billion, have risen about 17 percent so far this year, underperforming the 34-percent rise in the sector index .BSEHC and the main index's 19.5 percent gain. ($1= 44.3 rupees) (Reporting by Prashant Mehra; editing by Malini Menon)

      Nov 15, 2010


      Share this Article!

    Back to top^